Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) plus tiragolumab (Tira) and atezo plus placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+squamous cell carcinoma of the head and neck (SCCHN)
- Authors
- Cohen, E[Cohen, E.]; Fayette, J[Fayette, J.]; Harrington, KJ[Harrington, K. J.]; Johnson, ML[Johnson, M. L.]; Kao, HF[Kao, H-F.]; Lee, SH[Lee, S-H.]; Licitra, LF[Licitra, L. F.]; Ngamphaiboon, N[Ngamphaiboon, N.]; Psyrri, A[Psyrri, A.]; Wong, DJ[Wong, D. J.]; Afshari, M[Afshari, M.]; Cvijovic, K[Cvijovic, K.]; Goodman, GR[Goodman, G. R.]; Komatsubara, KM[Komatsubara, K. M.]; Matheny, C[Matheny, C.]; Pham, TQ[Pham, T. Q.]; Tang, H[Tang, H.]; Wang, L[Wang, L.]; Yan, Y[Yan, Y.]; Gillison, M[Gillison, M.]
- Issue Date
- 2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, pp.S814 - S815
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Start Page
- S814
- End Page
- S815
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.